Hiroshi Igeta
Hiroshi Igeta publishes mostly in Organic Chemistry, Molecular Biology and Physical and Theoretical Chemistry, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Biological Evaluation and Synthesis and Reactions of Organic Compounds.
- World rank
- #7,703,294 of 7,710,434 ranked researchers
- Rank in Japan
- #382,681 of 383,136
- Works
- 204
- Citations
- 1.2k
- Citations per work
- 5.6
What does Hiroshi Igeta research?
Hiroshi Igeta's work is mostly in Chemistry (86%), Biochemistry, Genetics and Molecular Biology (6%), Pharmacology, Toxicology and Pharmaceutics (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences17987.7%
- Chemistry17686.3%
- Environmental Science31.4%
- Life Sciences178.5%
- Everything else83.8%
- 1Organic Chemistry82% of their works
- 2Molecular Biology6% of their works
- 3Physical and Theoretical Chemistry3% of their works
- 4Pharmaceutical Science2% of their works
- 5Health, Toxicology and Mutagenesis1% of their works
- 6Spectroscopy1% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Synthesis and Reactions of Organic Compounds
- Synthesis and Reactivity of Heterocycles
- Chemical Reaction Mechanisms
- Synthesis and biological activity
- Phenothiazines and Benzothiazines Synthesis and Activities
- Structural and Chemical Analysis of Organic and Inorganic Compounds
Which keywords describe Hiroshi Igeta's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Heterocycles, Heterocyclic Compounds, Catalyst, Molecular Docking, Antimicrobial Activity and Antimicrobial.
- Oxadiazoles
- Biological Activities
- Tubulin Inhibitors
- Acidity Scales
- Bioactivity
- Imidazoles
- Derivatives
- Drug Discovery
- Anticancer Agents
- Antimicrobial
- Molecular Docking
- Heterocyclic Compounds
- Biological Evaluation
- Synthesis
- Heterocycles
- Catalyst
- Antimicrobial Activity
- Anticancer
- Medicinal Chemistry
- Triazines
- Quinoxaline
- Oxazolones
- Indolizines
- Nucleophilicity
- Vascular Targeting Agents
- Phenothiazines
- Thiadiazoles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 27 words, with their numbers
- Synthesis3376 topics
- Biological Evaluation2273 topics
- Heterocycles1793 topics
- Heterocyclic Compounds1593 topics
- Catalyst1552 topics
- Molecular Docking1492 topics
- Antimicrobial Activity1382 topics
- Antimicrobial1223 topics
- Anticancer1092 topics
- Anticancer Agents992 topics
- Medicinal Chemistry992 topics
- Drug Discovery891 topic
- Triazines891 topic
- Derivatives781 topic
- Quinoxaline781 topic
- Imidazoles771 topic
- Oxazolones771 topic
- Bioactivity601 topic
- Indolizines601 topic
- Acidity Scales481 topic
- Nucleophilicity481 topic
- Tubulin Inhibitors211 topic
- Vascular Targeting Agents211 topic
- Biological Activities201 topic
- Phenothiazines201 topic
- Oxadiazoles131 topic
- Thiadiazoles131 topic
Where does Hiroshi Igeta work?
Hiroshi Igeta's main affiliation in the publication record is SHOWA Medical University, Japan.
How many publications and citations does Hiroshi Igeta have?
OpenAlex counts 204 works and 1,152 citations for Hiroshi Igeta, an h-index of 17, ranking #7,703,294 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroshi Igeta. Posts are plain text and can be reported.